New study aims to safely prevent TB in pregnant women with HIV
NCT ID NCT05122026
First seen Jan 10, 2026 · Last updated May 01, 2026 · Updated 10 times
Summary
This study looks at two different ways to prevent tuberculosis (TB) in pregnant women who also have HIV. About 252 pregnant women will take either a daily TB prevention pill for one month or a weekly pill for three months. Researchers want to see if these treatments are safe for both the mother and baby, and if they affect the HIV medication dolutegravir.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FAMily Centre for Research with Ubuntu (FAMCRU)
Cape Town, Cape Town, 7505, South Africa
-
Peri Natal HIV Research Unit - Klerksdorp Tshepong Hospital
Klerksdorp, North West, 2571, South Africa
-
The Aurum Institute: Tembisa Clinical Research Centre
Tembisa, Gauteng, 1632, South Africa
Conditions
Explore the condition pages connected to this study.